Navigation Links
CRH experiences significant increase in business activity
Date:2/18/2009

VANCOUVER, Feb. 18 /PRNewswire-FirstCall/ - CRH Medical announced today that for the year ended December 31, 2008, it had 27,348 patient visits at its Centers for Colorectal Health compared to 13,461 for the same period in 2007. In addition, as a result of it's Partnership Program, the Company sold 6,840 units of its CRH O'Regan Hemorrhoid Banding Technology compared to 1,920 for the same period in 2007. The Company trained more than 100 physicians in its Partnership Program during the second half of 2008, versus only 9 physicians in 2007.

Commenting on the these results and plans going forward, Edward Wright, Chief Executive Officer, stated, "Although we do not yet have audited financial reports, we anticipate a significant increase in revenue in 2008 versus 2007, as well as a decrease in our losses. We continue to focus on cutting expenses and increasing our activities in our highest margin business segment, our Partnership Program in an attempt, to achieve cash flow positive operations as soon as possible in the current year. We are very excited about the opportunity our Partnership Program provides our partner physicians and their patients."

Through its Partnership Program the Company sells its patented proprietary hemorrhoid banding technology, treatment protocols, marketing and operational experience directly to physicians who see patients that may be in need of hemorrhoid treatment. By adopting the use of the CRH Technology, the physician increases practice revenues, expands the continuum of care and provides a fast, painless hemorrhoid solution to patients.

The Company expects to publish its full 2008 financial and annual report by the end of April, 2009.

About CRH Medical Corporation:

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner physicians. The Company's goal is to establish the CRH hemorrhoid technology as the standard for hemorrhoid treatment.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this release.


'/>"/>
SOURCE CRH Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Experiences Bring More Joy Than Possessions Do
2. Perceptions and experiences of homeless youth vary by race, UCSF study shows
3. A life with pain -- new study examines the experiences of older people
4. It takes 2 to know 1: Shared experiences change self-recognition
5. Experiences of rape unique to Rwandan women survivors of genocide
6. Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante
7. PaperThin Experiences Record Growth : Grows Revenues, Expands Channel, and Maintains 95%+ Subscription Renewal Rate
8. Racial and ethnic disparities detected in patient experiences
9. Seniors Gain Experiences of a Lifetime
10. Massachusetts Patients Offer Feedback on Their Experiences With Primary Care
11. Authoritative Report on Emergency Department Experiences Released Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: